Physiomics (PYC)

Sector:

Health Care

Index:

FTSE AIM All-Share

 1.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 3.15
  • 52 Week Low: 0.95
  • Currency: UK Pounds
  • Shares Issued: 135.47m
  • Volume: 960,461
  • Market Cap: £2.03m
  • RiskGrade: 504

Physiomics Overview

Physiomics’ vision is to transform oncology drug development. We believe in innovation, collaboration, diversity and inclusion and we aim to bring out the best in each other, in order to help our partners develop great cancer drugs and to apply them optimally in real-world settings.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -96.0% -52.9%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 3.4 2.1
Pr/Book 3.8  
Latest F'cast
Revenue -28.1% 42.3%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Physiomics Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-19 0.72 (0.20) (0.14)p n/a n/a n/a n/a 0.0%
30-Jun-20 0.80 (0.13) (0.09)p n/a n/a n/a n/a 0.0%
30-Jun-21 0.70 (0.34) (0.22)p n/a n/a n/a n/a 0.0%
30-Jun-22 0.83 (0.36) (0.26)p n/a n/a n/a n/a 0.0%
30-Jun-23 0.60 (0.57) (0.49)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Physiomics Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-24 0.85 (0.45) (0.25)p n/a n/a n/a n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Physiomics Company Announcements

Contract Award 18-Mar-2024 07:00 RNS
Interim Results 07-Mar-2024 07:00 RNS
Options Award 06-Feb-2024 07:00 RNS

Physiomics ShareCast News

Physiomics secures 'substantial new contract' wi... 18-Mar-2024 ShareCast
Physiomics revenue rises, losses narrow in first... 07-Mar-2024 ShareCast
Physiomics secures contract with University of S... 19-Feb-2024 ShareCast

Latest Physiomics Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Physiomics Market Data

Currency UK Pounds
Share Price 1.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 3.15
52 Week Low 0.95
Volume 960,461
Shares Issued 135.47m
Market Cap £2.03m
RiskGrade 504

Physiomics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
32.72% below the market average32.72% below the market average32.72% below the market average32.72% below the market average32.72% below the market average
41.94% below the sector average41.94% below the sector average41.94% below the sector average41.94% below the sector average41.94% below the sector average
Price Trend
63.53% below the market average63.53% below the market average63.53% below the market average63.53% below the market average63.53% below the market average
13.51% below the sector average13.51% below the sector average13.51% below the sector average13.51% below the sector average13.51% below the sector average
Income Not Available
Growth
59.01% below the market average59.01% below the market average59.01% below the market average59.01% below the market average59.01% below the market average
77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average

Physiomics Dividends

No dividends found

Trades for 25-Apr-2024

Time Volume / Share Price
16:02 16,000 @ 1.44p
16:02 100,000 @ 1.52p
15:33 198,450 @ 1.52p
15:15 145,551 @ 1.52p
15:13 63,929 @ 1.56p

Physiomics Key Personnel

COO Christophe Chassagnole
CEO Peter Sargent

Top of Page